Diagnosis of Occult Melanoma using Transient Receptor Potential Melastatin 1 (TRPM1) Autoantibody Testing: A Novel Approach

PURPOSE: To report the first case of melanoma-associated retinopathy (MAR) and underlying occult melanoma diagnosed based on the presence of serum transient receptor potential melastatin 1 (TRPM1) autoantibodies. DESIGN: Interventional case report with basic science correlation. PARTICIPANTS: One pa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ophthalmology
Autores principales: Dalal, Monica D., Morgans, Catherine W., Duvoisin, Robert M., Gamboa, Elizabeth A., Jeffrey, Brett G., Garg, Sunir J., Chan, Chi-Chao, Sen, H. Nida
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4928578/
https://ncbi.nlm.nih.gov/pubmed/24053997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2013.07.037
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares